C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 495/04 (2006.01) A61K 31/519 (2006.01) A61P 25/24 (2006.01) C07D 495/14 (2006.01)
Patent
CA 2517833
The invention relates to 5-HT receptor antagonists. Novel piperidinylamino- thieno[2,3-d] pyrimidine compounds represented by Formula I, and synthesis and uses thereof for treating diseases mediated directly or indirectly by 5-HT receptors, are disclosed. Such conditions include central nervous system disorders such as anxiety, depression, schizophrenia, neural injury, stroke, and migraine. Methods of preparation and novel intermediates and pharmaceutical salts thereof are also included.
L'invention concerne des antagonistes des récepteurs de la 5-HT. Cette invention concerne également de nouveaux composés de pipéridinylamino-thiéno[2,3-d] pyrimidine représentés par la formule (I) ainsi que la synthèse et des utilisations desdits composés dans le traitement de pathologies à médiation directe ou indirecte par des récepteurs de la 5-HT. Parmi ces pathologies figurent les troubles du système nerveux central, tels que l'anxiété, la dépression, la schizophrénie, les lésions neurales, l'accident vasculaire cérébral et la migraine. Ladite invention concerne en outre des méthodes de préparation, de nouveaux intermédiaires ainsi que des sels pharmaceutiques de ces composés.
Bar-Haim Shay
Becker Oren
Chen Dongli
Cheruku Srinivasa Rao
Dhanoa Dale S.
Borden Ladner Gervais Llp
Predix Pharmaceuticals Holdings Inc.
Trovis Pharmaceuticals Llc
LandOfFree
New piperidinylamino-thieno[2,3-d] pyrimidine compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with New piperidinylamino-thieno[2,3-d] pyrimidine compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and New piperidinylamino-thieno[2,3-d] pyrimidine compounds will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1870885